New Covid Variant and a possible new application of a 100+ year old hospital disinfectant to prevent Covid Infection/transmission/mutation?
Covid is believed to be transmitted through the nose, mouth, and eyes via epithelial cell ACE-2 receptor/doorways.
What if it’s possible to coat these ACE-2 receptor doorways with a dilute solution of PV-iodine which functions as both disinfectant and barrier to infection/transmission?
The New Eris mutant- US Today Article
PV-iodine Disinfectant used in many hospitals for over 100 years.
https://pubmed.ncbi.nlm.nih.gov/28648795/
Chemoprophylaxis of PV-Iodine mouthwash
against Covid Infection- PubMed/NIH articles
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498745/
As shown in Table 3 , although the available evidence is limited, a 30-s exposure to 0.5–1% PVP-I or 0.04–0.075% CPC appears to reduce the oropharyngeal load of SARS-CoV-2 and present a risk mitigation strategy for COVID-19 patients.
Safety and Tolerability of 0.6% PV-iodine Eye Drops – PubMed Article
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984652/
PV-iodine Opthalmic Uses – WebMD article
https://www.webmd.com/drugs/2/drug-156431/povidone-ophthalmic-eye/details
Hmm, 0.6 % Betadine is tolerable why not make 0.5% to prevent Covid entry through tear ducts in the eyes as well as use as a gargle and nose barrier to Covid infection?
https://fact-checked.org/2022/02/03/pv-iodine-throat-spray-effective-as-prophylaxis-against-cv19/
New COVID variant Eris: symptoms, how to protect yourself and others
Use a 0.5 % Betadine ( PV- Iodine) to gargle with and coat a Q-tip with 0.5% ( 1 ounce 10% Betadine plus 19 ounces of water) to coat inside of both nostrils.
This 0.5% Betadine solution will kill active virus and coat ACE-2 receptors on epithelial cells lining nose, throat , upper pharynx.
https://www.sigmapharmaceuticals.com/exam-medical-supplies/35-betadine-ophthalmic-prep-solution.html
Respectfully
EJ Ledet
Effective Thinking 